Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
Onset symptoms in paediatric multiple sclerosis.
Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development.
IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.
Low levels of vitamin d in neuromyelitis optica spectrum disorder: association with disease disability.
Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review.
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS.
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications.
Environmental Pathology: SY09-2 MULTIPLE SCLEROSIS (MS) AND NEURODEGENERATION: CAUSE AND PATHOGENESIS IN RELATION TO ELECTROMAGNETIC FIELDS (EMF).
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy.
Resting-state functional connectivity in multiple sclerosis: An examination of group differences and individual differences.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Menopause in multiple sclerosis: therapeutic considerations.
Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
THE CLINICAL SPECTRUM OF MICROCYSTIC MACULAR OEDEMA.
Study of fatigue frequency and its association with sociodemographic and clinical variables in patients with multiple sclerosis.
[Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? No].
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.
Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
Poster Abstracts from the Fourth International Symposium on Gait and Balance in Multiple Sclerosis: The Role of CognitionCleveland Clinic • Cleveland, Ohio, USA • October 10 & 11, 2014.
Pages
« first
‹ previous
…
435
436
437
438
439
440
441
442
443
…
next ›
last »